Patent · US Active

3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

US9353107B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignees

Aurigene Discovery Technologies Limited · IN
UM PHARMAUJI SDN. BHD. · MY

Inventors

Venkateshwar Rao Gummadi · Bengaluru, IN
Subramanya Hosahalli · Bengaluru, IN
Srinivas Nanduri · Hyderabad, IN
Girish Aggunda Renukappa · Mumbai, IN

Key dates

Filing date	Jul 1, 2013
Grant date	May 31, 2016
Priority date	—
Expiry date	Jul 1, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present application relates to novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives of formula (I), as protein kinase inhibitors.The invention particularly relates to compounds of formula (I), preparation of compounds and pharmaceutical compositions thereof. The invention further relates to pharmaceutically acceptable salts and compositions comprising the said novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives and their use in the treatment of various disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.